EMCDDA Publishes Its First Report on Health Responses to New Psychoactive Substances
Over the last decade, there has been an unprecedented rise in the number of new drugs appearing on the global market
Tìm kiếm
Long-term follow-up of patients treated with buprenorphine/naloxone
In the first long-term follow-up of patients treated with buprenorphine/naloxone (Bp/Nx) for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy. After 3.5 years...
2016 EU Drug Markets Report
The 2016 EU Drug Markets Report — In-depth Analysis is launched at a press conference in Brussels on 5 April by Dimitris Avramopoulos, European Commissioner for Migration, Home Affairs and Citizenship. The Commissioner will be joined by...
European Drug Report 2015
The EU Drug Agency (EMCCDA) has published the European Drug Report 2015. In its annual review, the agency reflects on 20 years of monitoring and examines the global influences and local ramifications of Europe’s ever-changing drugs problem...
Addiction Journal Organise Their Articles by Key Findings
'Addiction' the journal produced by the American Society for the Study of Addiction have created a useful resource for those involved with the study of addiction. They have compiled a list of all their articles published in 2015, with the...
Neuroscience of Psychoactive Substance Use and Dependence
This report describes our current understanding of the neuroscience of psychoactive substance use and dependence. It draws on the explosive growth in knowledge in this area in recent decades, which has transformed our understanding of the...
